tradingkey.logo

Caris Life Sciences Inc

CAI
查看详细走势图

33.660USD

+0.540+1.63%
收盘 09/16, 16:00美东报价延迟15分钟
9.46B总市值
亏损市盈率 TTM

Caris Life Sciences Inc

33.660

+0.540+1.63%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.63%

5天

-0.85%

1月

-7.78%

6月

0.00%

今年开始到现在

0.00%

1年

0.00%

查看详细走势图

TradingKey股票评分

暂无公司评分数据

新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

暂无数据

营业总收入

暂无数据

公司

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
公司代码CAI
公司Caris Life Sciences Inc
CEOMr. David Dean Halbert
网址https://www.carislifesciences.com/
KeyAI